HI
ASND icon

Hoey Investments’s Ascendis Pharma A/S ASND Stock Holding History

Hoey Investments’s Portfolio ASND Stock Details ASND Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-24
Closed -$3.27K – 373
2024
Q3 		$3.27K Hold
24
– – ﹤0.01% 276
2024
Q2 		$3.27K Hold
24
– – ﹤0.01% 276
2024
Q1 		$3.63K Hold
24
– – ﹤0.01% 267
2023
Q4 		$3.02K Hold
24
– – ﹤0.01% 276
2023
Q3 		$2.25K Buy
+24
New +$2.25K ﹤0.01% 293

Other funds holding ASND

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Hoey Investments's ASND Position: Q4 2024 in Review

Hoey Investments sold out of Ascendis Pharma A/S (ASND) in Q4 2024, closing a stake of 24 shares — an estimated $3.27K sold.

Hoey Investments first reported a position in ASND in Q3 2023 and held it in 5 quarters. The position peaked at $3.63K in Q1 2024. 214 funds tracked by Wall St. Rank hold ASND as of Q4 2024.

  • Hoey Investments reported no remaining Ascendis Pharma A/S position as of Q4 2024 after selling out during the quarter.
  • Hoey Investments sold 24 Ascendis Pharma A/S shares in Q4 2024, an estimated $3.27K.
  • Hoey Investments first reported a position in Ascendis Pharma A/S in Q3 2023 and held it in 5 quarters.
  • Hoey Investments's Ascendis Pharma A/S position peaked at $3.63K in Q1 2024.
  • 214 funds tracked by Wall St. Rank held Ascendis Pharma A/S as of Q4 2024.

Based on Hoey Investments's 13F filing for Q4 2024, filed 12 Feb 2025.